Phosphatase Activity Toward Abnormally Phosphorylated τ: Decrease in Alzheimer Disease Brain

• DOI: 10.1046/j.1471-4159.1995.65020732.x
• Publication Date: 2010-07-15T22:01:41Z
• Authors: Cheng‐Xin Gong; Sadia Shaikh; Jian‐Zhi Wang; Tanweer Zaidi; Inge Grundke‐Iqbal; Khalid Iqbal
• Keywords: Brain Chemistry; Male; Tissue Extracts; Brain; tau Proteins; Middle Aged; Phosphoric Monoester Hydrolases; Rats; 3. Good health; Rats, Sprague-Dawley; 03 medical and health sciences; 0302 clinical medicine; Alzheimer Disease; Reference Values; Animals; Humans; Female; Phosphorylation; Aged

Abstract: Microtubule‐associated protein τ is abnormally hyperphosphorylated and aggregated in affected neurons of Alzheimer disease brain. This hyperphosphorylated τ can be dephosphorylated at some of the abnormal phosphorylated sites by purified protein phosphatase‐1, 2A, and 2B in vitro. In the present study, we have developed an assay to measure protein phosphatase activity toward τ‐1 sites (Ser199/Ser202) using the hyperphosphorylated τ isolated from Alzheimer disease brain as substrate. Using this assay, we have identified that in normal brain, protein phosphatase‐2A and 2B and, to a lesser extent, 1 are involved in the dephosphorylation of τ. The Km values of dephosphorylation of the hyperphosphorylated τ by protein phosphatase‐2A and 2B are similar. The τ phosphatase activity is decreased by ∼30% in brain of Alzheimer disease patients compared with those of age‐matched controls. These findings suggest that a defect of protein phosphatase could be the cause of the abnormal hyperphosphorylation of τ in Alzheimer disease.